You have 9 free searches left this month | for more free features.

ofatumumab

Showing 1 - 25 of 68

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuromyelitis Optica Spectrum Disorder Trial in Xi'an (Ofatumumab)

Recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Ofatumumab
  • Xi'an, Shaanxi, China
    Tangdu Hospital
Aug 16, 2022

Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

Active, not recruiting
  • Small Lymphocytic Lymphoma
  • CLL (Chronic Lymphocytic Leukemia)
  • Fludarabine Phosphate
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 6, 2022

Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Ofatumumab
  • Los Angeles, California
    University of Southern California
Feb 3, 2022

Ocrelizumab and Ofatumumab Administration in Relapsing Multiple

Terminated
  • Relapsing Forms of Multiple Sclerosis
  • Lutherville, Maryland
  • +1 more
Feb 28, 2022

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Ofatumumab
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 23, 2022

Multiple Sclerosis Trial in Germany (Ofatumumab)

Active, not recruiting
  • Multiple Sclerosis
  • Ofatumumab
  • Berlin, Germany
  • +5 more
Aug 5, 2022

Immune Cells and Meningeal Lymphatic Drainage in Demyelinating

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • Ofatumumab
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Jun 15, 2022

Relapsing Multiple Sclerosis (RMS) Trial in United States (Ofatumumab, mRNA COVID-19 vaccine, interferon or glatiramer acetate)

Recruiting
  • Relapsing Multiple Sclerosis (RMS)
  • Ofatumumab
  • +2 more
  • Phoenix, Arizona
  • +3 more
Jul 20, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 2, 2021

Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)

Recruiting
  • Relapsing Multiple Sclerosis
  • Boston, Massachusetts
    Partners MS Center, 60 Fenwood Road
Jul 20, 2021

Relapsing Multiple Sclerosis Trial in United States (Quadrivalent influenza vaccine, Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Quadrivalent influenza vaccine
  • Ofatumumab
  • Phoenix, Arizona
  • +3 more
Aug 30, 2021

Relapsing Multiple Sclerosis Trial in Puerto Rico, United States (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • Birmingham, Alabama
  • +16 more
Mar 22, 2022

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021

Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in

Active, not recruiting
  • Stage I Mantle Cell Lymphoma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Buffalo, New York
  • +1 more
Mar 9, 2022

Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

Recruiting
  • Multiple Sclerosis (MS)
  • Little Rock, Arkansas
  • +44 more
Aug 24, 2022

Chronic Lymphocytic Leukemia Trial in Cologne (Bendamustine, Ofatumumab, Ibrutinib)

Completed
  • Chronic Lymphocytic Leukemia
  • Cologne, Germany
    German CLL Study Group
Jun 9, 2020

Nephrotic Syndrome Trial in Genoa (Ofatumumab, Placebo)

Terminated
  • Nephrotic Syndrome
  • Ofatumumab
  • Placebo
  • Genoa, Italy/GE, Italy
    IRCCS Istituto Giannina Gaslini
Jul 28, 2020

Nephrotic Syndrome Trial in Genoa (Ofatumumab, Rituximab)

Completed
  • Nephrotic Syndrome
  • Genoa, Italy/GE, Italy
    IRCCS Istituto Giannina Gaslini
Jul 28, 2020

Multiple Sclerosis Trial in Worldwide (Ofatumumab, First line DMT)

Recruiting
  • Multiple Sclerosis
  • Ofatumumab
  • First line DMT
  • Bayonne, Bayonne Cedex, France
  • +42 more
Jul 25, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • IPI-145 (duvelisib)
  • Ofatumumab
  • La Jolla, California
  • +68 more
Mar 15, 2021

Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

B-cell Lymphoid Leukemia, Young Patients Trial in Italy (Cyclophosphamide, Fludarabine, Ofatumumab)

Completed
  • B-cell Lymphoid Leukemia
  • Young Patients
  • Alessandria, Italy
  • +21 more
Oct 12, 2020

Chronic Lymphocytic Leukemia, Fatigue, Fever Trial in Houston (Lenalidomide, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 16, 2019

Non-Hodgkin's Lymphoma Trial in Grand Island, Omaha (Lenalidomide, ofatumumab)

Completed
  • Non-Hodgkin's Lymphoma
  • Grand Island, Nebraska
  • +1 more
Feb 20, 2019